about
Mucinex® ER 600 mg Bi-Layer Tablet Fed and FastedStudy to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy VolunteersBioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy VolunteersStudy to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.Effectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Acute Bronchitis.Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone BitartrateMucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4hWarming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)Exploratory Efficacy Study of Guaifenesin in Upper Back PainSafety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract InfectionsClinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute CougherThe Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot StudyEffect of Cafedrine/Theodrenaline and Urapidil on Cerebral OxygenationStudy to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release TabletStudy to Evaluate the Pharmacokinetics of Guaifenesin in Adults and AdolescentsStudy With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to GlucocorticoidsStudy to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest CongestionBioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions
P4844
Q62025477-37A70D9D-06A9-4B29-830B-2515C3551D44Q62025933-5F5FA43B-51FB-4B31-978D-F0D1274F22BBQ62025935-99E855F3-881F-4F34-8C80-70F9B4C2A173Q62025978-C5F6368D-98DE-44CA-8074-E9A03040BE93Q62035232-A8B1B5C6-9DF1-464D-ABFD-6FB6EC5E16C7Q62062751-E5E2616A-40A3-42AC-BB71-B31B29B7D3C8Q62062795-67911FD8-7DE2-4213-8FDC-838E139CC79EQ63315656-31E44FAE-AF1D-4A63-9E9A-F7011A150FA2Q63316146-11610E6D-DB5E-4C07-987B-9E8F39CF2AF8Q63320149-5C679E39-ECDC-4D1B-A7E0-912B0BBA8C67Q63322860-179A2D13-6284-4487-AB5C-41E388E52EB5Q63334149-1B804FE9-5B01-401A-84E2-759ADEBC3E4FQ63339161-3E847B78-7FE4-447B-A442-314BAF7F63D0Q63394521-A23370DC-09EF-49DE-85B2-9C864C53A7DAQ63394527-F7AEDAD3-C9C8-47CB-AC72-B4E36864B1B6Q63592581-72AE7367-DACA-43DD-9D07-323D38B8EA71Q63597502-F599C3F7-293E-4436-A48D-3767762232DFQ63599563-6382206F-36B5-4837-8EDD-46AE451A5183
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
(+)-Norephedrin
@de
(+)-norefedryna
@pl
(+)-phenylpropanolamine
@en
(+)-фэнілпрапаналамін
@be-tarask
Fenilpropanolamin
@id
Fenilpropanolamin
@sh
Fenilpropanolamin
@sr-el
Fenilpropanolamina
@es
Fenilpropanolamina
@pt
Fenilpropanolamino
@eo
type
label
(+)-Norephedrin
@de
(+)-norefedryna
@pl
(+)-phenylpropanolamine
@en
(+)-фэнілпрапаналамін
@be-tarask
Fenilpropanolamin
@id
Fenilpropanolamin
@sh
Fenilpropanolamin
@sr-el
Fenilpropanolamina
@es
Fenilpropanolamina
@pt
Fenilpropanolamino
@eo
altLabel
(+)-Phenylpropanolamin
@de
(1S,2R)-2-Amino-1-phenyl-propan-1-ol
@de
(1S,2R)-Phenylpropanolamin
@de
(1S,2R)-fenylopropanoloamina
@pl
14838-15-4
@fr
2-amino-1-phenylpropan-1-ol
@cy
2-amino-1-phenylpropan-1-ol
@en
492-41-1
@fr
ATC kod R01BA01
@sr
ATCvet kod QR01BA01
@sr
prefLabel
(+)-Norephedrin
@de
(+)-norefedryna
@pl
(+)-phenylpropanolamine
@en
(+)-фэнілпрапаналамін
@be-tarask
Fenilpropanolamin
@id
Fenilpropanolamin
@sh
Fenilpropanolamin
@sr-el
Fenilpropanolamina
@es
Fenilpropanolamina
@pt
Fenilpropanolamino
@eo
P2175
P2868
P31
P3364
P4964
P486
P592
P646
P661
P662
P665
P683
P2017
C[C@H]([C@H](C1=CC=CC=C1)O)N
P2057
HMDB0001942
P2067
151.099714
P2115
N0000147978
P231
37577-28-9